CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth

DSpace Repository

CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth

Author: Huynh, Tony; Murray, Jayne; Flemming, Claudia L.; Kamili, Alvin; Hofmann, Ute; Cheung, Leanna; Roundhill, Elizabeth A.; Yu, Denise M. T.; Webber, Hannah T.; Schwab, Matthias; Henderson, Michelle J.; Haber, Michelle; Norris, Murray D.; Fletcher, Jamie, I
Tübinger Autor(en):
Hofmann, Ute
Schwab, Matthias
Published in: Biochemical Pharmacology (2020), Bd. 172, Article UNSP 113770
Verlagsangabe: Pergamon - Elsevier Science Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.bcp.2019.113770
ISSN: 1873-2968
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)